Iglehart JD - Search Results

1

Abnormalities of the inactive X chromosome are a common feature of BRCA1 mutant and sporadic basal-like breast cancer.

Ganesan S, Richardson AL, Wang ZC, Iglehart JD, Miron A, Feunteun J, Silver D, Livingston DM. Ganesan S, et al. Among authors: iglehart jd. Cold Spring Harb Symp Quant Biol. 2005;70:93-7. doi: 10.1101/sqb.2005.70.045. Cold Spring Harb Symp Quant Biol. 2005. PMID: 16869742

2

X chromosomal abnormalities in basal-like human breast cancer.

Richardson AL, Wang ZC, De Nicolo A, Lu X, Brown M, Miron A, Liao X, Iglehart JD, Livingston DM, Ganesan S. Richardson AL, et al. Among authors: iglehart jd. Cancer Cell. 2006 Feb;9(2):121-32. doi: 10.1016/j.ccr.2006.01.013. Cancer Cell. 2006. PMID: 16473279 Free article.

3

BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles.

Matros E, Wang ZC, Lodeiro G, Miron A, Iglehart JD, Richardson AL. Matros E, et al. Among authors: iglehart jd. Breast Cancer Res Treat. 2005 May;91(2):179-86. doi: 10.1007/s10549-004-7603-8. Breast Cancer Res Treat. 2005. PMID: 15868446

4

Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays.

Wang ZC, Buraimoh A, Iglehart JD, Richardson AL. Wang ZC, et al. Among authors: iglehart jd. Breast Cancer Res Treat. 2006 Jun;97(3):301-9. doi: 10.1007/s10549-005-9124-5. Breast Cancer Res Treat. 2006. PMID: 16791486

5

Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers.

Wang ZC, Lin M, Wei LJ, Li C, Miron A, Lodeiro G, Harris L, Ramaswamy S, Tanenbaum DM, Meyerson M, Iglehart JD, Richardson A. Wang ZC, et al. Among authors: iglehart jd. Cancer Res. 2004 Jan 1;64(1):64-71. doi: 10.1158/0008-5472.can-03-2570. Cancer Res. 2004. PMID: 14729609

6

Genomic approaches in cancer biology.

Matros E, Wang ZC, Richardson AL, Iglehart JD. Matros E, et al. Among authors: iglehart jd. Surgery. 2004 Sep;136(3):511-8. doi: 10.1016/j.surg.2004.05.040. Surgery. 2004. PMID: 15349094 Review. No abstract available.

7

The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy.

Golshan M, Miron A, Nixon AJ, Garber JE, Cash EP, Iglehart JD, Harris JR, Wong JS. Golshan M, et al. Among authors: iglehart jd. Am J Surg. 2006 Jul;192(1):58-62. doi: 10.1016/j.amjsurg.2005.12.005. Am J Surg. 2006. PMID: 16769276

8

Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations.

Birkbak NJ, Kochupurakkal B, Izarzugaza JM, Eklund AC, Li Y, Liu J, Szallasi Z, Matulonis UA, Richardson AL, Iglehart JD, Wang ZC. Birkbak NJ, et al. Among authors: iglehart jd. PLoS One. 2013 Nov 12;8(11):e80023. doi: 10.1371/journal.pone.0080023. eCollection 2013. PLoS One. 2013. PMID: 24265793 Free PMC article.

9

SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis.

Cheng H, Liu P, Wang ZC, Zou L, Santiago S, Garbitt V, Gjoerup OV, Iglehart JD, Miron A, Richardson AL, Hahn WC, Zhao JJ. Cheng H, et al. Among authors: iglehart jd. Sci Signal. 2009 Jul 21;2(80):ra35. doi: 10.1126/scisignal.2000369. Sci Signal. 2009. PMID: 19622832 Free PMC article.

10

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer.

Li Y, Zou L, Li Q, Haibe-Kains B, Tian R, Li Y, Desmedt C, Sotiriou C, Szallasi Z, Iglehart JD, Richardson AL, Wang ZC. Li Y, et al. Among authors: iglehart jd. Nat Med. 2010 Feb;16(2):214-8. doi: 10.1038/nm.2090. Epub 2010 Jan 24. Nat Med. 2010. PMID: 20098429 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page